QLS-101

· Qlaris Bio, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for QLS-101, covering 2025-01-17 to 2025-01-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety and Tolerability of QLS-101 in NTG [Phase 2]